Cite

HARVARD Citation

    Luo, H. et al. (2018). Suramin is a novel competitive antagonist selective to α1β2γ2 GABAA over ρ1 GABAC receptors. Neuropharmacology. pp. 148-157. [Online]. 
  
Back to record